Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions
-
Published:2019-10
Issue:
Volume:48
Page:191-202
-
ISSN:2352-3964
-
Container-title:EBioMedicine
-
language:en
-
Short-container-title:EBioMedicine
Author:
Alcala Nicolas, Mangiante Lise, Le-Stang NolwennORCID, Gustafson Corinne E., Boyault Sandrine, Damiola Francesca, Alcala Karine, Brevet Marie, Thivolet-Bejui Françoise, Blanc-Fournier Cécile, Le Rochais Jean-Philippe, Planchard Gaëtane, Rousseau Nathalie, Damotte Diane, Pairon Jean Claude, Copin Marie Christine, Scherpereel Arnaud, Wasielewski Eric, Wicquart Laurence, Lacomme Stéphanie, Vignaud Jean-Michel, Ancelin Gaspard, Girard Cécile, Sagan Christine, Bonnetaud Christelle, Hofman Véronique, Hofman Paul, Mouroux Jérôme, Thomas de Montpreville Vincent, Clermont-Taranchon Estelle, Mazieres Julien, Rouquette Isabelle, Begueret Hugues, Blay Jean-YvesORCID, Lantuejoul Sylvie, Bueno Raphael, Caux Christophe, Girard Nicolas, McKay James D., Foll Matthieu, Galateau-Salle Françoise, Fernandez-Cuesta LynnetteORCID
Funder
Ligue Contre le Cancer Institut National Du Cancer
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference48 articles.
1. Dose-time-response association between occupational asbestos exposure and pleural mesothelioma;Lacourt;Occup Environ Med,2017 2. Classification of tumours of the lung, pleura, thymus and heart;World Health Organization. WHO,2015 3. EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach;Nicholson;J Thorac Oncol (In Press),2019 4. New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH reference center;Galateau Salle;J Thorac Oncol: Off Pub Int Assoc Study Lung Cancer,2018 5. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet (London, England),2016
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|